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Deletion of Fas in adipocytes relieves adipose tissue
inflammation and hepatic manifestations of obesity in mice
Abstract
Adipose tissue inflammation is linked to the pathogenesis of insulin resistance. In addition to exerting
death-promoting effects, the death receptor Fas (also known as CD95) can activate inflammatory
pathways in several cell lines and tissues, although little is known about the metabolic consequence of
Fas activation in adipose tissue. We therefore sought to investigate the contribution of Fas in adipocytes
to obesity-associated metabolic dysregulation. Fas expression was markedly increased in the adipocytes
of common genetic and diet-induced mouse models of obesity and insulin resistance, as well as in the
adipose tissue of obese and type 2 diabetic patients. Mice with Fas deficiency either in all cells or
specifically in adipocytes (the latter are referred to herein as AFasKO mice) were protected from
deterioration of glucose homeostasis induced by high-fat diet (HFD). Adipocytes in AFasKO mice were
more insulin sensitive than those in wild-type mice, and mRNA levels of proinflammatory factors were
reduced in white adipose tissue. Moreover, AFasKO mice were protected against hepatic steatosis and
were more insulin sensitive, both at the whole-body level and in the liver. Thus, Fas in adipocytes
contributes to adipose tissue inflammation, hepatic steatosis, and insulin resistance induced by obesity
and may constitute a potential therapeutic target for the treatment of insulin resistance and type 2
diabetes.
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Fas expression is increased in adipocytes isolated from insulin-resistant mice 





























































Fas expression is increased in adipocytes isolated from insulin-resistant mice and in adipose tissue of obese and diabetic patients. (A) Total 
cell lysates were prepared from isolated perigonadal adipocytes harvested from db/db, ob/ob, and WT control mice. Lysates were resolved by 
LDS-PAGE and immunoblotted with anti-Fas or anti-actin antibody. Results are mean ± SEM of 3 mice per group and normalized to actin expres-
sion. *P < 0.05 (Student’s t test). (B) Total cell lysates were prepared from isolated adipocytes of perigonadal fat pads of chow-fed and HFD-fed 
(8 weeks of HFD) mice. Lysates were resolved by LDS-PAGE and immunoblotted with anti-Fas or anti-actin antibody. Results are mean ± SEM 
of 3 mice per group and normalized to actin expression. *P < 0.05 (1-sample t test). (C) Total RNA was extracted from perigonadal fat pads, and 
quantitative RT-PCR was performed. The level of mRNA expression was normalized to 18S RNA. Results represent mean ± SEM of 3 animals 
per group. *P < 0.05, **P < 0.01 (Student’s t test). (D) Tissue lysates from subcutaneous fat biopsies of lean, obese, and diabetic patients were 
prepared and immunoblotted with anti-Fas or anti-actin antibody. Results are mean ± SEM of 5–10 patients per group and normalized to actin 
expression. *P < 0.05 (ANOVA).
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Figure 
Fas-def mice are protected from 
HFD-induced changes in adipose 
tissue and glucose homeostasis. 
(A) Weight gain was analyzed in 
HFD-fed WT and Fas-def mice. 
Results are mean ± SEM of 10 
animals per group. (B) Perigonad-
al fat pads were harvested and 
weighed. Results are expressed 
relative to total body weight and 
represent mean ± SEM of 10–15 
mice group. *P < 0.05 (Student’s 
t test). (C) Left: Relative size dis-
tribution of adipocyte diameter 
after 6 weeks of HFD. Results 
represent mean ± SEM of 6 mice 
per group. Right: Mean adipocyte 
diameter of chow- or HFD-fed 
Fas-def and WT mice. Results 
represent mean ± SEM of 6 mice 
per group. *P < 0.05 (Student’s t 
test). (D) Intraperitoneal glucose 
tolerance tests in WT (left) and 
Fas-def (right) mice. Results are 
mean ± SEM of 12–18 animals 
per group. *P < 0.05, **P < 0.01 
(Student’s t test). (E) Fasting 
insulin levels were determined in 
WT (left) and Fas-def (right) mice 
after 8 hours of food withdrawal. 
Results are mean ± SEM of 4–5 
animals per group. *P < 0.05 
(Student’s t test). (F) 14C-d-glu-
cose incorporation into isolated 
adipocytes from chow- and HFD-
fed mice was determined in the 
absence or presence of insulin. 
Left: Fold glucose incorporation 
in WT mice. Right: Fold glucose 
incorporation in Fas-def mice. 
Results represent mean ± SEM 
of 6 experiments. **P < 0.01 (Stu-
dent’s t test).
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AFasKO mice are protected against HFD-induced adipocyte insulin resis-



















tion  to  adipocytes,  thereby 
influencing  adipose  tissue 
biology.  However,  Cre  was 




previous  studies  using  the 
same Fabp4-Cre strain (19, 23). 
















































Fas activation in 3T3-L1 adipocytes decreases insulin sensitivity and stimulates lipolysis. Mature 3T3-L1 adipo-
cytes were incubated with 2 ng/ml FasL for 12 hours. (A) 3H-2dG glucose uptake was determined after treatment 
with or without insulin at different concentrations. Shown are absolute values of 3H-2dG uptake in untreated or 
FasL-treated 3T3-L1 adipocytes. Results are mean ± SEM of 5–9 independent experiments. *P < 0.05 (ANOVA). 
(B) Glycerol release was determined after medium was removed and cells were incubated with KREBS buffer for 
another hour. Results represent mean ± SEM of 4 independent experiments. **P < 0.01 (1-sample t test).
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Fas deletion in adipocytes may prevent adipocyte and whole-body insulin 



























Characterization of AFasKO mice. (A) Total cell lysates were prepared from isolated adipocytes of WT (Fasfl/fl;Fabp4-Cre–/–) and AFasKO (Fasfl/fl; 
Fabp4-Cre+/–) mice. Lysates were resolved by LDS-PAGE and immunoblotted with anti-Fas or anti-actin antibody. (B and C) Tissue lysates 
were prepared and resolved by LDS-PAGE and immunoblotted with anti-Fas or anti-actin antibody. (D) Total cell lysates (80 μg) from adipocytes 
and macrophages were prepared, resolved by LDS-PAGE, and immunoblotted with anti-Cre or anti-actin antibody. (E) Total cell lysates from 
resident and activated macrophages were prepared, resolved by LDS-PAGE, and immunoblotted with anti-Fas or anti-actin antibody. (F) Weight 
gain was analyzed in WT and AFasKO mice. Results are mean ± SEM of 14–15 animals per group. (G) Different fat pads were harvested and 
weighed. Results are expressed relative to total body weight and represent mean ± SEM of 14 mice per group. *P < 0.05. peri, perigonadal; retro, 
retroperitoneal; mes, mesenteric. (H) The size of isolated perigonadal adipocytes was analyzed. For each mouse, at least 100 adipocytes were 
analyzed. Images were analyzed using NIH ImageJ software for quantification. Results represent mean ± SEM of 4–5 mice per group.
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Fas ablation in adipocytes protects against liver steatosis and insu-
























































































Plasma levels of glucose, insulin, FFAs, TG, glycerol, adipokines, 
and cytokines of HFD-fed WT and AFasKO mice
	 WT	 AFasKO
Blood glucose (mmol/l) 10.6 ± 0.3 9.4 ± 0.4A
Insulin (pmol/l) 98.5 ± 17.7 89.1 ± 7.8
FFAs (mmol/l) 1.36 ± 0.06 1.33 ± 0.04
TG (mg/dl) 85.9 ± 4.1 85.9 ± 6.5
Glycerol (mg/dl) 6.72 ± 0.37 6.52 ± 0.38
Adiponectin (μg/ml) 52.9 ± 5.7 56.4 ± 4.4
Resistin (pg/ml) 4,465 ± 516 5,251 ± 730
Leptin (pg/ml) 1,270 ± 305 1,240 ± 209
MCP-1 (pg/ml) 47.5 ± 12.9 35.1 ± 7.8
IL-6 (pg/ml) 7.6 ± 0.9 4.6 ± 1.0A
KC (pg/ml) 481 ± 139 278 ± 54
TNF-α ND ND
Results are mean ± SEM of 5–9 independent experiments. ND, not 
detectable (limit of detection, 3 pg/ml). AP < 0.05 (Student’s t test).
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AFasKO mice are protected from HFD-induced deteriorations in glucose metabolism. (A) 14C-d-glucose incorporation into isolated perigonadal 
adipocytes from WT (Fasfl/fl;Fabp4-Cre–/–) and AFasKO (Fasfl/fl;Fabp4-Cre+/–) mice was determined in the absence or presence of insulin. Results 
are expressed relative to basal uptake and represent mean ± SEM of 5 independent experiments performed in triplicate. *P < 0.05 (Student’s 
t test). Intraperitoneal glucose (B) and insulin (C) tolerance tests (ipGTT and ipITT) were performed in WT (filled circles) and AFasKO (open 
circles) mice. Inset graphs in B and C depict the respective analysis of the area under the curve. Results are mean ± SEM of 8–10 animals per 
group. *P < 0.05, **P < 0.01 (Student’s t test). (D) Steady-state glucose infusion rates during hyperinsulinemic-euglycemic clamps. Results are 
mean ± SEM of 3–4 animals per group. **P < 0.01 (Student’s t test). (E) Plasma FFA levels in HFD-fed WT and AFasKO mice before and at the 
end of a euglycemic-hyperinsulinemic clamp are depicted. Results are mean ± SEM of 3 animals per group. *P < 0.05 (Student’s t test).
Figure 
Reduced inflammatory profile in HFD-fed 
AFasKO mice. (A) Quantitative RT-PCR 
detection of mRNA expression in WAT. The 
level of mRNA expression was normalized 
to 18S RNA. Results are mean ± SEM of 
5–9 animals per group. *P < 0.05, **P < 0.01 
(Student’s t test). (B) Plasma concentration of 
IL-6. Results represent mean ± SEM of 5 ani-
mals per group. *P < 0.05 (Student’s t test).
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Increased secretion of immunoattractant cytokines and higher macrophage adherence in FasL-
treated 3T3-L1 adipocytes. (A) Fas ligation increases expression of proinflammatory cytokines 
in 3T3-L1 adipocytes. Mature 3T3-L1 adipocytes were incubated in the presence or absence 
of 2 ng/ml FasL for 12 hours. Medium was removed, and cells were incubated with KREBS 
buffer. Cytokine levels were then determined in the supernatant. Shown are results normalized 
to untreated cells. Results represent mean ± SEM of 4–5 independent experiments. *P < 0.05 
(1-sample t test). (B) Mature 3T3-L1 adipocytes were incubated in the presence or absence 
(control [Co]) of 2 ng/ml FasL for 12 hours. Thereafter, adipocytes were incubated with 3H-labeled 
macrophages for 1 hour at 37°C. Cells were washed and lysed (0.05N NaOH). Finally, radioactiv-
ity of lysates was determined by a beta counter. Results represent mean ± SEM of 7 independent 
experiments. *P < 0.05 (1-sample t test).
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Reduced hepatic steatosis in HFD-fed AFasKO mice. (A) H&E-stained liver sections from WT (Fasfl/fl;Fabp4-Cre–/–) and AFasKO (Fasfl/fl;Fabp4-
Cre+/–) mice (original magnification, ×40). Total liver lipids were determined and expressed relative to lipid content in WT mice. Results repre-
sent mean ± SEM of 8 mice of each group. *P < 0.05 (Student’s t test). (B) Levels of detected liver ceramide species are shown. Results are 
mean ± SEM of 6–8 animals per group and are expressed relative to total lipids in WT mice. *P < 0.05 (Student’s t test). n.d., not detected. (C) 
mRNA expression of indicated markers in liver tissue of WT and AFasKO mice was analyzed. Results are mean ± SEM of 5–9 mice per group, 
expressed relative to WT and normalized to expression of 18S. *P < 0.05 (Student’s t test). (D and E) Liver lysates were prepared from WT and 
AFasKO mice and resolved by LDS-PAGE. (D) Lysates were immunoblotted with ADRP, PPARγ, or actin antibodies. Results are mean ± SEM 
of 4–6 animals per group and expressed relative to protein expression in WT mice. *P < 0.05 (Student’s t test). (E) Lysates were immunoblotted 
with anti–phospho–p65 NF-κB or anti-actin antibody. Expression levels of phospho-p65 are normalized to expression of actin. Results are 
mean ± SEM of 5–6 mice and expressed relative to WT.
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Improved hepatic insulin sensitivity in AFasKO mice. (A) Lysates were immunoblotted with anti–phospho-IRS1 (Ser307) and total IRS1 antibody. 
Expression levels of pSer307 are normalized to expression of total IRS1. Results are mean ± SEM of 4 mice and expressed relative to WT. *P < 0.05 
(Student’s t test). (B) Hepatic glucose production was calculated in the basal period and in response to insulin infusion during the hyperinsulinemic-
euglycemic clamp study. Results are mean ± SEM of 3–4 animals per group and expressed relative to basal hepatic glucose production. **P < 0.01 
(Student’s t test). (C) 3T3-L1 adipocytes were incubated with or without FasL for 12 hours, and subsequently, supernatant was collected for 24 hours. 
Hepatoma cells (Fao) were incubated with the conditioned medium for 24 hours. Total cell lysates were prepared and resolved by LDS-PAGE and 
immunoblotted with anti–phospho-Akt or Akt antibody. Results are mean ± SEM of 7–9 independent experiments. **P < 0.01 (ANOVA).
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m1;  ArgI, Mm00475988_m1;  IL-10, Mm00439614_m1;  adiponectin, 
Mm00456425_m1; PPARγ, Mm00440945_m1; PEPCK, Mm0044636_


























































































	 The	Journal	of	Clinical	Investigation      http://www.jci.org




















  7. Klover  PJ,  Zimmers  TA,  Koniaris  LG, Mooney 














Acad Sci U S A. 2007;104(8):2861–2866.
  12. Wajant H, Pfizenmaier K, Scheurich P. Non-apop-









growth  factor  receptor  and  activation  of MAP 
kinases. J Biol Chem. 2008;283(2):919–928.
  15. Imamura R, et al. Fas ligand induces cell-autono-




  16. Miwa K,  et  al.  Caspase  1-independent  IL-1beta 
release and inflammation induced by the apoptosis 
inducer Fas ligand. Nat Med. 1998;4(11):1287–1292.
  17. Schaub FJ,  et  al.  Fas  and Fas-associated  death 





  18. Fischer-Posovszky  P,  Tornqvist  H,  Debatin 
KM, Wabitsch M. Inhibition of death-receptor 
mediated  apoptosis  in  human  adipocytes  by 















































  32. Winzen  R,  Wallach  D,  Kemper  O,  Resch  K, 
Holtmann H. Selective up-regulation of the 75-
kDa tumor necrosis factor (TNF) receptor and 






















hepatic  insulin  resistance.  J Clin Invest.  2004; 
114(2):232–239.
  39. Yang  X,  Smith  U.  Adipose  tissue  distribution 
and  risk  of  metabolic  disease:  does  thiazoli-
dinedione-induced  adipose  tissue  redistribu-

















































extraction and purification. Can J Biochem Physiol. 
1959;37(8):911–917.
  53. Pfaffl MW. A new mathematical model for relative 
quantification in real-time RT-PCR. Nucleic Acids 
Res. 2001;29(9):e45.
  54. Souza SC, et al. Modulation of hormone-sensitive 
lipase and protein kinase A-mediated lipolysis by 
perilipin A in an adenoviral reconstituted system. 
J Biol Chem. 2002;277(10):8267–8272.
  55. Fukuzumi M, Shinomiya H, Shimizu Y, Ohishi K, 
Utsumi S. Endotoxin-induced enhancement of glu-
cose influx into murine peritoneal macrophages 
via GLUT1. Infect Immun. 1996;64(1):108–112.
